drugset / Trial / NCT01437189

The Effects of Sertraline on Depression in Parkinson's Disease

NCT01437189

Completed 35 enrolled Zhejiang University
NaSingle-groupOpen-labelTreatment

Summary

The aim of this open-label, self-control study is to evaluate the efficacy of sertraline in treating depression in Patients with Parkinson's disease. In addition, the investigators also want to find out whether patient gets better quality of life when depression is improved.

Timeline

Start
2011-08-01
Primary completion
2013-08-01
Completion
2013-11-01

Drugs

EvaluationDrugModalityDoseRoute
Subject Sertraline Small molecule